ALPHEN AAN DEN RIJN (NL) – 26 August 2021 – Life Science Newswire – Sakura Finetek Europe appointed Mr. Mateo Iglesias as Vice President of Marketing & Sales EMEAI. Mateo starts September 1st and will be responsible for all marketing and sales activities for Sakura's fast-growing markets.

Mateo has over 20 years of experience with (bio)medical companies. For the last fifteen years, he worked for Agilent Technologies, as Associate Vice President EMEAI. His proven leadership capabilities and marketing & sales experience will be a massive benefit in this new role.

Focus on people and culture

The new Vice President is honoured and thrilled of his appointment and has a clear vision: 'I believe in the employees of Sakura. They are the key to the strong brand Sakura Finetek Europe is today. I will focus on extending our solid culture of innovation, teamwork, and customer centricity to be able to empower pathology professionals, now and in the future.'

Chris Koeman, General Manager at Sakura Finetek Europe: 'We look forward working together with Mateo. We believe he has the experience and drive to enable the ambitious plans Sakura has. His progressive and human approach is what makes him the ideal candidate to help us bring Sakura to the next level.'

More about Sakura Finetek Europe

At Sakura Finetek Europe we advance cancer diagnostics by providing integrated solutions for anatomic pathology and patients through best-in-class innovations, quality and customer care. This is how Sakura became the original manufacturer of Tissue-Tek^®, Cyto-Tek^®, Tissue-Tek VIP^® and Tissue-Tek Xpress^®, today’s industry standards. With headquarters based in Alphen aan den Rijn (NL) and seven regional locations in Europe we empower pathology professionals in the whole EMEAI region. For more information visit www.sakura.eu, follow us on LinkedIn, or contact us via communication@sakura.eu.